Insmed
INSM
#963
Rank
NZ$44.06 B
Marketcap
NZ$200.88
Share price
1.71%
Change (1 day)
-30.64%
Change (1 year)

EPS for Insmed (INSM)

EPS in 2026 (TTM): NZ-$7.10

According to Insmed's latest financial reports the company's current EPS (TTM) is NZ-$7.27. In 2025 the company made an earnings per share (EPS) of NZ-$11.35 a decrease over its 2024 EPS that were of NZ-$9.89.

EPS history for Insmed from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$7.10-37.38%
2025NZ-$11.3514.67%
2024NZ-$9.89
2022NZ-$6.900.78%
2021NZ-$6.8528.57%
2020NZ-$5.33-0.99%
2019NZ-$5.38-27.96%
2018NZ-$7.4747.55%
2017NZ-$5.060.7%
2016NZ-$5.0339.9%
2015NZ-$3.599.73%
2014NZ-$3.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.79-262.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
NZ-$4.60-36.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$30.67-521.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ-$4.65-36.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.33-81.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ-$1.73-76.16%๐Ÿ‡บ๐Ÿ‡ธ USA